News
Filter
-
MRC Technology and Chinese Academy of Science extend collaboration to identify new targets for drug discovery
-
UCB and UK’s MRC Technology sign exclusive license agreement for a fibrosis programme
-
£3m Dementia Consortium launched to boost dementia drug discovery
-
MRC Technology to Oversee Parkinson’s UK Intellectual Property
-
MRC Technology and Oxford University Collaborate to Develop Novel Pain Therapeutics for Migraine
-
MRC Technology to join innovation network at Stevenage Bioscience Catalyst
-
MRC Technology and Boston University Collaborate to Develop anti-IL-16 Antibody for Treatment of Inflammatory Conditions
-
MRC Technology and Renishaw Diagnostics Collaborate to Identify and Develop Infectious Disease Diagnostics
-
MRC Technology advises Bergen TO in successful technology transfer programme
-
MRC Technology and Arthritis Research UK Launch Joint ‘Call for Targets’
-
MRC Technology and Parkinson’s UK launch joint ‘Call for Targets’ to slow, stop or reverse the progression of Parkinson’s
-
MRC Technology highlights presentation of data for antibody candidate lambrolizumab developed using its humanization technology
